Related Experiment Video
Updated: Dec 18, 2025

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
CNS inflammatory vasculopathy with antimyelin oligodendrocyte glycoprotein antibodies in COVID-19
Ashwin A Pinto1, Liam S Carroll2, Vijay Nar2
1From the Wessex Neurological Centre (A.A.P., L.S.C., V.N., A.V., I.G.), Southampton General Hospital, Southampton, UK; and Clinical Neurosciences (A.A.P., A.V., I.G.), Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, UK. Ashwin.Pinto@nhs.net.
No abstract available in PubMed .
More Related Videos
10:47Simple and Efficient Production and Purification of Mouse Myelin Oligodendrocyte Glycoprotein for Experimental Autoimmune Encephalomyelitis Studies
Published on: October 27, 2016
08:17Author Spotlight: Unveiling the Pathway Linking Obesity to Autoimmune Inflammation in Multiple Sclerosis
Published on: February 23, 2024
Related Concept Videos
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Myocarditis I: Introduction